Articles of Vaccines

News »

Diaz-Canel praises pediatric clinical trials against Covid-19 in Cuba

niños covid

Cuban President Miguel Diaz-Canel on Friday described as transcendental the approval by health authorities of the start of the anti-Covid-19 clinical trials in pediatric people, using the vaccine candidates from the Caribbean island. The proven safety of Soberana02 and SoberanaPlus has made it possible to take this step, among the first in the world, said the president on his Twitter account, where he thanked Cuban scientists for this achievement.

News »

Havana clinics prepare for mass vaccination against COVID-19

cuba vacunacion

Although health authorities have yet to set the starting date for mass vaccination against COVID-19 in Cuba, authorities in Havana are working at an accelerated pace to prepare clinical sites that will undertake the important, complex task. According to the digital version of the weekly Tribuna de La Habana, next Saturday, April 24, both the logistic and human resources to guarantee the quality of the process should be defined, including the selected medical offices and polyclinics.

News »

COVID-19 Vaccines: Stories of monopoly, blackmail and inequality

Randy opinion covid

The apprehensions raised in some countries by the AstraZeneca/Oxford vaccine, the US dirty campaign against the Russian Sputnik V and the confirmed refusal of the most powerful nations to let their pharmaceutical companies temporarily release the patents of their antidotes against COVID-19, have further strained the availability of vaccines and deepened the profound differences in the right to life between the powerful and the poor in this world.
Never before has a health emergency struck so many in so many places and in such a short space of time. COVID-19 has already affected more than 120 million people in the world and has caused the death of more than 2.6 million human beings.

News »

Thirty-five COVID-19 landmarks in Cuba

Cuba vacunas estudios

Between March 11, 2020 and the same day in 2021, so many events have transpired – so many unprecedented – that what we have experienced is beyond the capacity of these newspaper pages. But we are alive, and confident that the day will come when there will be no deaths, no one in serious condition, no one infected. Hope lies in massive immunization of the population and in the power of solidarity, thus we propose a summary of what has happened in Cuba as this period draws to a close.

News »

Soberana 02, the first Latin American vaccine in phase III trials

Soberana

The Center for State Control of Medicines, Equipment and Medical Devices (Cecmed) has authorized the initiation of phase III clinical trials of the Soberana 02 candidate vaccine, after a rigorous analysis of the documentation submitted by the Finlay Vaccine Institute on findings gathered thus far. President of the Republic of Cuba Miguel Díaz-Canel Bermúdez yesterday also posted a tweet noting that phase III clinical trials were at hand for Soberana 02 and Abdala, in Havana, Santiago de Cuba and Guantánamo, with more than 85,000 volunteers.

News »

Cuba reports 1,039 Covid-19 new cases and five deaths

covid-cuba-enfermo

The national director of Epidemiology at the Cuban Ministry of Public Health (MINSAP), Dr. Francisco Duran, reported 1,039 new Covid-19 cases and five deaths over the last 24 hours. At his regular press conference on television on Sunday, Dr. Duran explained that 18,156 PCR tests in real time were made to detect the SARS-CoV-2 coronavirus, which causes Covid-19.

News »

Cuba improves health protocols, produces Covid-19 vaccine candidates

Soberana-02

Cuba is currently improving its health protocols to fight the Covid-19 pandemic, while producing its most-advanced vaccine candidate, ¨Soberana 02¨, on a large scale, in order to begin phase III of clinical trials in March. During the latest meeting of the temporary working group, it was insisted on the need to speed up the results of the PCR tests.

News »

Cuba scales up industrial production of candidate vaccines

Cuba Vacunas

Industrial production has begun of Cuba’s candidate vaccines Soberana 02 and Abdala (CIGB-66), two of the four developed on the island to combat COVID-19, with progress advancing at BioCubaFarma facilities. Cuba has begun the process of scaling up industrial production of Cuba’s candidate vaccines Soberana 02 and Abdala (CIGB-66), two of the four developed on the island to combat COVID-19.

News »

A million doses of COVID-19 vaccines to be available in April

mesa redonda biocubafarma

The director of the Finlay Vaccine Institute, Vicente Vérez Bencomo, stated that mass production of the Soberana series of candidate vaccines has begun, and Cuba can expect to have one million doses on hand in April. He explained that the manufacturing process is underway for 100,000 doses to supply broader clinical trials of Soberana 01 and Soberana 02.

News »

Everything to know to date about the four Cuban vaccine candidates against COVID-19

Soberana-01

Cuba currently has four vaccine candidates in clinical trials. What are the characteristics of each one? What results have they produced so far? What steps is the country taking to confront the new strains of the SARS-CoV2 virus? To learn about these issues, the president of BioCubaFarma, the general director of the Center for Genetic Engineering and Biotechnology, the general director of the Finlay Vaccine Institute.